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We used phylogenomic and risk factor data on isolates of Sal-
monella enterica serovars Mississippi and Typhimurium de-
finitive type 160 (DT160) collected from human, animal, and 
environmental sources to elucidate their epidemiology and 
disease reservoirs in Australia and New Zealand. Sequence 
data suggested wild birds as a likely reservoir for DT160; ani-
mal and environmental sources varied more for Salmonella 
Mississippi than for Salmonella Typhimurium. Australia and 
New Zealand isolates sat in distinct clades for both serovars; 
the median single-nucleotide polymorphism distance for 
DT160 was 29 (range 8–66) and for Salmonella Mississippi, 
619 (range 565–737). Phylogenomic data identified plausible 
sources of human infection from wildlife and environmental 
reservoirs and provided evidence supporting New Zealand–
acquired DT160 in a group of travelers returning to Austra-
lia. Wider use of real-time whole-genome sequencing in new 
locations and for other serovars may identify sources and 
routes of transmission, thereby aiding prevention and control.
Nontyphoidal Salmonella enterica subsp. enterica causes substantial illness and death throughout the 
world (1,2). In Australia, rates of notified infection are 
higher than in other high-income countries (3). Preventing 
infection by understanding sources and routes of transmis-
sion and controlling outbreaks rapidly is key to reducing 
the rate of salmonellosis in Australia. Whole-genome se-
quencing (WGS) is increasingly being used as a tool to help 
with prevention and control by investigating the relation-
ship between isolates, sources of infection, and routes of 
transmission (4). Evidence shows that WGS is useful in 
foodborne nontyphoidal S. enterica outbreak detection and 
control (5–7).
On mainland Australia (Figure 1), Salmonella Ty-
phimurium is the most commonly notified nontyphoidal 
S. enterica serovar. In contrast, Salmonella Mississippi is 
the most commonly notified nontyphoidal S. enterica se-
rovar infecting residents of the island state of Tasmania, 
where 2.1% of the population of Australia resides (3,8). 
Most persons with Salmonella Mississippi who are resi-
dents of mainland Australia have traveled to Tasmania or 
one of several Pacific Islands to which Salmonella Missis-
sippi was endemic during their exposure period (9,10). In 
Tasmania, Salmonella Mississippi has been isolated from 
wildlife, and some evidence indicates that human infec-
tions might result from environmental transmission more 
frequently than from foodborne transmission (9,11). A 
case–control study in Tasmania during 2001–2002 found 
that case-patients were more likely than controls to have 
had indirect contact with native birds, consumed untreated 
drinking water, and traveled within the state (9), although 
the sources of infection and vehicles of transmission are 
still largely unknown.
Salmonella Typhimurium definitive type 160 (DT160) 
has more recently emerged in Tasmania, while remaining 
rare in the rest of the country. In 2008, ten years after its 
emergence in humans in New Zealand, the first locally ac-
quired case of DT160 was reported in Tasmania; unusual 
sparrow (Passer domesticus) deaths were observed in the 
same area in 2009, consistent with sparrow deaths in New 
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Zealand in 2000 (12–15). Since then, DT160 has affected 
≈50 Tasmania residents and ≈3,000 New Zealand residents 
and has been associated with wild bird deaths in both coun-
tries (16–18). Although a case–control study conducted 
in 2001 in New Zealand suggested that handling of dead 
wild birds, contact with persons with diarrheal illness, and 
ingestion of fast food were associated with illness (12), 
the relationship between the Tasmania and New Zealand 
DT160 infections and the relationship between animal and 
human isolates in Tasmania is unknown. Accordingly, we 
aimed to use these 2 nontyphoidal S. enterica serovars as 
case studies to investigate how epidemiologic and genomic 
data can be integrated to better understand the geographic 
niche and transmission pathways of these organisms to 
subsequently improve prevention and control strategies.
Methods
Ethics Considerations and Data Sources
The Australian National University Human Research Eth-
ics Committee (2016/269) granted ethics approval for this 
project. We used data from the Australian National Notifi-
able Diseases Surveillance System (18) and the New Zea-
land Enteric Reference Laboratory (19) to examine trends 
in Salmonella Mississippi and DT160 in Australia and New 
Zealand. Population denominator data were obtained from 
the Australian Bureau of Statistics (8) and Statistics New 
Zealand (20). We used postcode of residence to determine 
Australian state or territory. Travel information was not 
available, so postcode might not represent place of acquisi-
tion for all notifications.
We collated epidemiologic data obtained through en-
hanced surveillance of cases of Salmonella Mississippi and 
DT160 that were notified to the Department of Health and 
Human Services in Tasmania, the Department of Health 
and Human Services in Victoria, and Queensland Health. 
Case-patients were interviewed at the time of notification 
using a standardized questionnaire, and this information 
was collected under each jurisdiction’s public health leg-
islation. For human isolates for which sequence data were 
available, we obtained the following case data fields from 
these questionnaires: type of case (sporadic, household, 
cluster, outbreak); hospitalization (yes/no); symptoms; 
travel; close contact with farm animals, native animals, 
birds, or pets (yes/no and type); lives on a rural property 
(yes/no); bushwalking or camping (yes/no); water source 
(public, private, or bottled); gardening (yes/no); swimming 
(yes/no); other risk factors (free text). Data on risk factors 
were collected for the week before illness onset.
Isolate Selection
For Salmonella Mississippi, we selected 34 human iso-
lates from Tasmania residents and 28 human isolates 
from residents of other states and territories in Australia 
that were referred for characterization to the Microbio-
logical Diagnostic Unit Public Health Laboratory (MDU 
PHL) in Melbourne during January 1, 2011–December 
31, 2015, for WGS (Appendix, https://wwwnc.cdc.gov/
EID/article/25/9/18-1811-App1.pdf). We also selected 
all viable isolates with a recorded source from 42 animal 
sources and 18 environmental sources in the MDU PHL 
collection with an isolation date from January 1, 2000, 
through December 31, 2016; these isolates were all from 
Tasmania. For DT160, all viable isolates held in the MDU 
PHL collection at the beginning of 2016 were included in 
genomic analysis.
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Figure 1. Relative locations  




MDU PHL performed DNA extraction and WGS for the 
Australia isolates. Sequence libraries were prepared us-
ing NexteraXT and sequenced on the Illumina NextSeq500 
platform (Illumina, https://www.illumina.com) with 150 bp 
paired-end reads. Reads are available from the National Cen-
ter for Biotechnology Information Sequence Read Archive 
(PRJNA319593). Salmonella Typhimurium L2 (accession 
no. NC003197 [https://www.ncbi.nlm.nih.gov/nuccore/
NC_003197.2]) was used as a reference for DT160, and 
because complete genomes were not publicly available, we 
used a local reference (AUSMDU00020775) for Salmonella 
Mississippi by assembling 1 of the isolates in this analysis 
(Appendix). We included 10 publicly available draft assem-
blies from 2011 through 2013 from New Zealand and the 
United States (Appendix) in the Salmonella Mississippi anal-
ysis (21,22) and 106 publicly available DT160 genomes from 
1992 through 2012 from humans, wild birds, poultry, and 
bovine sources in New Zealand in the DT160 analysis (16).
Salmonella Mississippi and DT160 genomes were an-
alyzed separately using Nullarbor version 2 (https://github.
com/tseemann/nullarbor). Short-read data of the isolates 
were mapped to the reference using Snippy version 4.0-
dev2 (https://github.com/tseemann/snippy). The 10 public-
ly available Salmonella Mississippi draft assemblies were 
also mapped to the Salmonella Mississippi reference using 
Snippy , with the –ctgs parameter that enables mapping of 
assembly contigs to a reference. A core genome alignment 
was produced using Snippy-core (v4.0-dev 2), and the re-
sulting full alignment was then filtered for recombination 
using Gubbins (23) using the weighted Robinson-Foulds 
method to estimate convergence with an initial 10 itera-
tions. The resulting recombination-filtered core genome 
alignment of 8,573 bases for Salmonella Mississippi and 
2,203 bases for DT160 was then passed to RAxML ver-
sion 8.2.11 (24) to infer maximum-likelihood (ML) phylo-
genetic trees, using the generalized time-reversible model 
with a γ-distribution to model site-specific rate variation 
and ascertain bias correction. For each analysis, we used 
3 independent runs with 1,000 bootstrap pseudoreplicates 
to assess branch support, with the phylogenetic trees with 
the highest support across the 3 runs used as the final tree 
for each analysis. The pairwise single-nucleotide polymor-
phism (SNP) distances between isolates were calculated 
from the recombination-filtered core genome alignment us-
ing afa-pairwise.pl within Nullarbor. De novo genome as-
semblies were generated using SPAdes version 3.12.0 (25), 
and the presence of known antimicrobial resistance genes 
was investigated using ABRicate (https://github.com/tsee-
mann/abricate) in conjunction with the genome assemblies 
and the National Center for Biotechnology Information an-
timicrobial resistance database with a minimum coverage 
of 90% and minimum identity of 90%.
Data Analysis
We collated epidemiologic and SNP data in Microsoft Ex-
cel 2013 (https://www.microsoft.com) and performed de-
scriptive analyses in Stata SE 14 (https://www.stata.com). 
We used sequence data to explore hypotheses about the 
epidemiologic relatedness of isolates. We compared risk 
factors between DT160 and Salmonella Mississippi cases 
using a 2-sample test of proportions. Based on SNPs be-
tween isolates of each serovar with known epidemiologic 
links (household or epidemiologic cluster), we considered 
isolates within 8 SNPs of each other for DT160 and 10 
SNPs of each other for Salmonella Mississippi a putative 
phylogenetic cluster for further investigation.
Results
Salmonella Mississippi
During January 1, 2000–December 31, 2016, the me-
dian annual notification rate of Salmonella Mississippi in 
Tasmania was 15 cases (range 12–24 cases) per 100,000 
population, compared with a notification rate of 0.11 cases 
(range 0.007–0.16 cases) per 100,000 population on main-
land Australia and 0.3 cases (range 0.16–0.47 cases) per 
100,000 population in New Zealand (Figure 2). In Australia, 
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Figure 2. Notification rates for Salmonella enterica serovar Mississippi, Tasmania (A) and mainland Australia and New Zealand (B), 
2000–2016. Rates are per 100,000 population.
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934 (50.5%) of 1,851 notifications occurred in female pa-
tients. Children 0–4 years of age were the most frequently 
notified age group (458 [24.7%]). Notification rates were 
higher in warmer months, similar to those for other non-
Typhimurium serovars (26).
For sequenced Salmonella Mississippi isolates, the ML 
tree showed that the isolates from Vanuatu, United States, 
and New Zealand were distinctly different from the Austra-
lia isolates (Figure 3); median SNP distance was 619 (range 
565–737) between Australia and New Zealand isolates 
(Appendix Figure 1) and 1,625 (range 963–1,923) between 
Australia and Vanuatu or US isolates. An isolate from a 
17-week-old mainland Australia resident with no history 
of overseas travel grouped on the phylogenetic tree with 
the isolates acquired in Vanuatu. Within the large Austra-
lia group, the 114 isolates were diverse; median SNP dis-
tance was 169 (range 3–649). Of these Australia isolates, 
24 (21.1%) of 114 were within 10 SNPs of another isolate 
and grouped into 8 phylogenetic clusters. The Australia hu-
man isolates grouped with Australia animal and environ-
mental isolates over several years. We observed consider-
able genetic diversity between isolates from various animal 
sources. For example, isolates from wombats were a me-
dian of 87 (range 44–97) SNPs apart, and isolates from bo-
vines were a median of 140 (range 10–201) SNPs apart. We 
did not detect any antimicrobial resistance genes in these 
isolates, except for 1 human isolate from Tasmania that had 
the blaTEM-1 gene, which mediates resistance to ampicillin.
Travel data were available for 51 (82%) of 62 of 
case-patients in Australia residents for which an isolate 
was sequenced. Of these, 6 (12%) reported international 
travel to Vanuatu and 19 (37%) reported domestic travel 
during their incubation period; 8 traveled from mainland 
states to Tasmania, 9 traveled within Tasmania, 1 traveled 
from Queensland to South Australia, and 1 traveled from 
Victoria to Queensland. Three Tasmania isolates investi-
gated as an epidemiologic cluster clustered genetically and 
temporally with an isolate from Victoria, for which no epi-
demiologic data were available. Although 2 other phylo-
genetic clusters included >1 human isolate, epidemiologic 
data were limited for these cases, and the infections were 
not clustered in time. Although not statistically significant, 
among case-patients who resided in or were known to have 
acquired infection in Tasmania and answered risk factor 
questions about exposures, a higher proportion of Salmo-
nella Mississippi than DT160 case-patients reported drink-
ing water from an untreated raw water source (i.e., tank, 
spring, or bore) (61% vs. 40%; p = 0.1) and camping (8% 
vs. 0%; p = 0.07) (Appendix Table 4). A similar propor-
tion of DT160 and Salmonella Mississippi cases reported 
bushwalking (8% vs. 7.5%; p = 0.94), gardening (16% vs. 
22%; p = 0.56), and swimming (16% vs. 18%; p = 0.84) 
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Figure 3. Maximum-likelihood 
phylogeny of 132 sequenced 
Salmonella enterica serovar 
Mississippi isolates from Australia 
and New Zealand and reference 
isolates, inferred from 8,573 core 
single-nucleotide polymorphisms. 
Nodes are labeled with isolation 
year, isolate source if nonhuman 
(all from Tasmania), and Australia 
state of acquisition or residence if 
human. Tree visualized with iTOL 
(https://itol.embl.de) and midpoint 
rooted. Scale bar indicates 
nucleotide substitutions per site. 
*State of residence was used 
instead of state of acquisition 
because no travel data were 
available. †Investigated as part of 
an epidemiologic cluster. A color 




exposures. Of the 13 case-patients who resided in or ac-
quired their infection in an Australia state other than Tas-
mania, 4 (31%) reported eating oysters during the expo-
sure period, including 2 cases in a phylogenetic cluster; 
however, not all case-patients were asked specifically 
about oysters.
Salmonella Typhimurium DT160
A total of 61 DT160 cases in Australia residents were noti-
fied during 1999–2014. The 12 infections reported in Aus-
tralia residents before 2008 were believed to be acquired 
overseas, including cases on an Australia–New Zealand 
cruise in 2003. Most Australia DT160 notifications had a 
postcode of residence in Tasmania, where the median an-
nual rate per 100,000 population of DT160 in the 9 years 
from 1999 to 2007 was 0 cases and in the 7 years from 
2008 to 2014 was 1.2, peaking at 2.8 in 2009, when 14 
cases occurred. In New Zealand, the median annual rate 
per 100,000 population of DT160 in the 9 years from 1999 
to 2007 was 6, peaking at 20.4 in 2001, when 791 cases 
occurred. In the 7 years from 2008 to 2014, the median 
annual rate was 1.6 per 100,000 population (Figure 4). Of 
all 61 Australia notifications during 1999–2014, a total of 
34 (56%) occurred in females, and children aged 0–4 years 
were the most frequently notified age group (14 [23%]). 
Because of the small number of cases, we found no clear 
seasonal pattern.
Of Australia isolates, we sequenced 62 human and 30 
animal isolates (20 from sparrows). The ML tree of Austra-
lia and New Zealand isolates showed 2 distinct groups; 1 
comprised isolates from humans and animals in Australia, 
and 1 comprised humans and animals from New Zealand 
and the 7 Australia residents who had reported travel to 
New Zealand (Figure 5). The median pairwise SNP dif-
ference between the Australia and New Zealand groups 
was 29 (range 8–66), and the median pairwise SNP dif-
ference within each group was 21 (Australia, range 2–56; 
New Zealand, range 0–55) (Appendix Figure 4). Within 
the Australia group, 45 (53%) of 85 isolates were within 
8 SNPs of another isolate, and the isolates grouped into 8 
phylogenetic clusters. Of these 8 phylogenetic clusters, 3 
contained >2 isolates; isolates from humans and birds over 
several years clustered. No known antimicrobial resistance 
genes were detected among any of the isolates.
Epidemiologic risk factor data were available for 55 
(90%) of the 61 DT160 cases in Australia residents from 
the 62 sequenced human isolates (1 person contributed 2 
isolates, 13 days and 7 SNPs apart). Of these 55 persons, 7 
(12%) of 59 acquired their infection in New Zealand, 6 in 
2003 on an Australia–New Zealand cruise, and 1 in 2009. 
All others were residents of, or had traveled to, Tasmania, 
except for 1 case-patient, who was a resident of New South 
Wales and had no reported travel outside the state. Two 
separate household clusters were investigated in 2012 and 
were phylogenetically clustered. In 2015, five isolates were 
investigated as part of an epidemiologic cluster; however, 
no epidemiologic link was found, and they were subse-
quently found not to be phylogenetically clustered (median 
SNPs 25.5, range 9–33). A higher proportion of DT160 
case-patients than Salmonella Mississippi case-patients re-
ported direct contact with wild or domestic animals (88% 
vs. 68%; p = 0.04) (Appendix Table 4).
Discussion
Phylogenomics plays a valuable role in identifying plau-
sible sources of Salmonella infection from wildlife and 
environmental reservoirs. For both serovars considered 
in this article, the integration of clinical and genomic data 
enhanced existing evidence on source reservoirs by show-
ing that human and animal or environmental isolates were 
genetically interspersed. Phylogenomic analysis revealed 
genetic diversity and persistence of Salmonella Mississippi 
strains in the environment and animals, suggesting it is en-
demic with a broad range of host reservoirs in Tasmania 
that is persisting over time. As in other countries (16,27–
29), genomic analysis provided evidence that wild birds 
are a source of human infection with DT160. No character-
ized antimicrobial resistance genes were detected in any of 
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Figure 4. Salmonella enterica serovar Typhimurium definitive type 160 notification rate, Tasmania and mainland Australia (A) and New 
Zealand (B), 1999–2014. Rates are per 100,000 population.
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the DT160 draft genome sequences, suggesting low or no 
antimicrobial resistance, consistent with other Salmonella 
strains found in wild birds (30,31).
In contrast to Salmonella Mississippi, Salmonella Ty-
phimurium DT160 isolates from Australia and New Zea-
land were similar, suggesting possible recent trans-Tasma-
nia transmission of DT160 through wildlife, as well as its 
potential to spread from Tasmania to the Australia main-
land. Further, the inferred population structure of these 
Australia strains provided evidence for this hypothesis of 
import and subsequent microevolution within the Australia 
strains. In New Zealand, DT160 has been transmitted be-
tween multiple hosts, and humans have been infected from 
multiple sources (16). Other Salmonella serovars with wild 
bird reservoirs have been transmitted to cattle, pigs, sheep, 
and poultry (32). The incidence of human infection in Aus-
tralia most likely would increase if DT160 were to become 
established in local animal food sources.
Epidemiologic evidence that 88% of DT160 case-
patients had direct animal contact and the close genetic 
relatedness between Australia human and animal isolates 
suggest that DT160 in Tasmania is predominantly a lo-
cally acquired zoonotic infection. Control measures should 
therefore focus on promoting hand hygiene after contact 
with wild birds and other animals, keeping food prepa-
ration and eating areas free from birds, treating drinking 
water that is accessible to birds and other animals, and 
appropriately cleaning and maintaining birdfeeders (32,33). 
In addition to monitoring the effect of such measures, con-
tinued isolation, identification, and WGS of DT160 isolates 
from humans, animals, and the environment could be used 
to monitor emergence in other settings that pose particular 
risks to the food supply and provide early warning of the 
need for specific control measures.
Risk factors for Salmonella Mississippi are less evident, 
although the proportion of case-patients who reported drink-
ing water from a private source (61%) was similar to that of 
an Australia case–control study of Salmonella Mississippi 
(63% of case-patients vs. 23% of controls reported drinking 
any untreated water; adjusted odds ratio 6.13, 95% CI 3.19–
11.76) (9). The range of animal and environmental sources 
and the high genetic diversity make identifying control strat-
egies difficult. Because genomic analyses of WGS data have 
detected clusters when epidemiologic links are obscured (7), 
prospective WGS of case isolates and integration of WGS 
data from human, animal, and environmental isolates could 
help to identify putative clusters for targeted epidemiologic 
investigation. Source attribution studies might enable quan-
tification of the contribution of raw water as a vehicle for 
Salmonella Mississippi infection in Tasmania.
One limitation of this study is that our sampling frame 
for sequencing and analysis might not have produced a 
representative sample of all infections; however, we tried 
to maximize variability of sources and isolation dates. 
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Figure 5. Maximum-likelihood 
phylogeny of 198 sequenced 
Salmonella enterica serovar 
Typhimurium definitive type 
160 isolates from Australia 
and New Zealand and 
reference isolates, inferred 
from 2,203 core single-
nucleotide polymorphisms, 
Australia and New Zealand. 
Nodes are labeled with isolate 
type and isolation year. All 
Australian isolates are from 
Tasmania unless specified 
otherwise. Figure created 
with iTOL (https://itol.embl.
de). Scale bar indicates 
nucleotide substitutions per 
site. *Specimens from the 
same person. †Investigated 
as part of an epidemiologic 
cluster. ‡Acquired in New 
South Wales. A color version 




Although epidemiologic risk factor data were incomplete 
for sequenced human cases, sufficient data were available 
for us to generate hypotheses that could be further inves-
tigated. Our case–case method is not as robust as a case–
control study with a neutral control group, but we believe 
it is a reasonable point of comparison, emphasizing the 
difference in risk between these 2 serovars. Some more 
recent Australia DT160 notifications might not have been 
captured by the national notification system because phage 
typing for Salmonella Typhimurium is being phased out 
across Australia. However, we believe this omission would 
be a small number because phage typing continued in most 
of the country until 2016 (M. Valcanis, MDU PHL, pers. 
comm., 2018 Oct 10). Without phage typing, and as the use 
of WGS for Salmonella surveillance becomes more rou-
tine, it will be difficult to compare new isolates with histori-
cally phage-typed isolates that have not been sequenced.
We used SNP thresholds based on known epidemio-
logic clusters to define putative phylogenetic clusters and 
to examine epidemiologic risk factors. Because SNPs de-
pend on the reference genome and the isolates in the analy-
sis, SNP thresholds for cluster analysis are likely to differ 
according to context. Local references were unavailable for 
both serovars in this study. We assembled a reference for 
Salmonella Mississippi using an isolate in this study, and 
the Salmonella Typhimurium isolate used was a median of 
899 (range 883–921) SNPs from the DT160 isolates in our 
study. A closer reference for DT160 might have provided 
higher resolution of the relatedness of isolates. Few inter-
national Salmonella Mississippi genomes were publicly 
available. Therefore, the relationship we found between 
Australia and New Zealand isolates might not be repre-
sentative of all Salmonella Mississippi isolates in these 2 
countries. Although beyond the scope of this study, iden-
tifying the most recent common ancestor using Bayesian 
phylogeographic analyses would improve our understand-
ing of endemic strains such as Salmonella Mississippi and 
the translocation of emerging strains such as DT160.
Wildlife can contribute to substantial rates of endemic 
and epidemic infection from Salmonella. For these 2 Sal-
monella serovars with wild animal and environmental res-
ervoirs in Australia and New Zealand, WGS combined with 
epidemiologic risk factor data provided some evidence for 
prevention and control efforts demonstrating the potential 
benefits of using WGS for prospective Salmonella surveil-
lance. Real-time sequencing of these strains could help mon-
itor emergence and identify clusters, enabling epidemiolo-
gists to more accurately identify common risk factors and 
aid in source attribution. Local references, publicly available 
international genomes, phylogeographic analyses, additional 
tools to define a WGS cluster, and source-assigned case–
control studies would improve our understanding of the epi-
demiology of these 2 Salmonella serovars in this region.
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